Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AP53532PU-N - Provider product page
- Provider
- Acris Antibodies GmbH
- Proper citation
- Acris Antibodies GmbH Cat#AP53532PU-N, RRID:AB_11145620
- Product name
- anti UQCRQ (C-term)
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide - KLH conjugated - corresponding to the C-terminal region (between 52-82aa) of human UQCRQ.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Vial size
- 0.1 mg
- Concentration
- 0.25 mg/ml
No comments: Submit comment
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Western blot analysis in WiDr cell line lysates (15ug/lane) using UQCRQ antibody Cat.-No. AP53532PU-N (C-term). This demonstrates the UQCRQ antibody detected UQCRQ protein (arrow).
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Western blot analysis in mouse bladder tissue lysates (15ug/lane) using v antibody Cat.-No. AP53532PU-N (C-term). This demonstrates the UQCRQ antibody detected UQCRQ protein (arrow).
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Immunohistochemistry analysis in human skeletal muscle (Formalin-fixed, Paraffin-embedded) using UQCRQ antibody Cat.-No. AP53532PU-N (C-term), followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the UQCRQ antibody for IHC. Clinical relevance has not been evaluated.
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image
- Experimental details
- Flow cytometric analysis of WiDr cells (right histogram) compared to a negative control cell (left histogram) using UQCRQ antibody Cat.-No. AP53532PU-N (C-term), followed by FITC-conjugated goat-anti-rabbit secondary antibodies.
